http://www.chemocentryx.com
ChemoCentryx, Inc. Company Intro
Positive topline data from pivotal Phase III ADVOCATE trial demonstrates avacopan’s superiority over standard of care in ANCA-associated vasculitis.
Industry
Healthcare
ChemoCentryx, Inc. Headquaters
850 Maude Avenue
Mountain View,94043
United States
ChemoCentryx, Inc. Share price
17 May 2023 12:56 GMT
$0
0.0 (0 %)
ChemoCentryx, Inc. Market cap
$
WMC RANKING
2023
ChemoCentryx, Inc. # 83
BiotechnologyLatest ChemoCentryx, Inc. News
07 Dec 2023
Markt für ANCA-Vaskulitis-Medikamente wird bis 2030 ...
ChemoCentryx, Inc., GlaxoSmithKline plc, Kineta, Inc. Darüber hinaus enthält der Forschungsbericht detaillierte Informationen zu den Hauptakteuren und...
07 Dec 2023
Focal Segmental Glomerulosclerosis Pipeline Analysis, 2023 ...
Braun Melsungen AG, Beckman Coulter Inc. (Danaher), Baxter International Inc., ChemoCentryx Inc., Complexa Inc., Dimerix Ltd, Medtronic PLC, Pfizer Inc...
07 Dec 2023
Markt für ANCA-Vaskulitis-Medikamente wird bis 2030 ...
ChemoCentryx, Inc., GlaxoSmithKline plc, Kineta, Inc. Darüber hinaus enthält der Forschungsbericht detaillierte Informationen zu den Hauptakteuren und...
WMC Market Score
WMC Market to Revenue Score
ChemoCentryx, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| ChemoCentryx, Inc. | USD | $68,760 | $131,141 | $-63,380 | $ | 83 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total ChemoCentryx, Inc. Social Followers vs Top 4 Industry Competitors
ChemoCentryx, Inc. Post vs Top 4 Industry Competitors
ChemoCentryx, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
ChemoCentryx, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
ChemoCentryx, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| ChemoCentryx, Inc. | 0.75 | 2.86 | 0.02 | 0 | 0 | 0 | 1.24 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
